SCHEMBL18154696

SCHEMBL18154696

CC(C)(c1cccnc1)S(=O)(=O)c1ccc(Sc2nccc(N)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.36
▸ POLB P06746 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ DUSP10 Q9Y6W6 1/20 0.33
▸ CYP2C9 P11712 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP11B1 P15538 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ NAPRT Q6XQN6 1/20 0.31
▸ PTGS2 P35354 3/20 0.31
▸ PTGS1 P23219 1/20 0.31
▸ CA2 P00918 2/20 0.31
▸ CA12 O43570 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30353134 1.00 LMNA (0.36) LMNAPOLBALDH1A1HTTSMN1; SMN2
SCHEMBL18154705 0.84 KDM4E (0.34) LMNAPOLB
SCHEMBL18154782 0.80 HSP90AA1 (0.33) LMNAHSP90AA1
SCHEMBL18154843 0.78 RAB9A (0.34) ALDH1A1
SCHEMBL18154846 0.76 MTOR (0.41) PTGS2
SCHEMBL18154672 0.76 KDM4E (0.32) LMNAALDH1A1CYP2C9TDP1
SCHEMBL30353164 0.75 PIK3C3 (0.42) LMNAALDH1A1TDP1CA2
SCHEMBL18154717 0.75 PIK3C3 (0.42) LMNAALDH1A1TDP1CA2
SCHEMBL18154735 0.73 HTR6 (0.42) LMNAALDH1A1CYP2C9CYP3A4ALOX5AP
SCHEMBL18154795 0.67 NAMPT (0.38) LMNAPOLBALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283482-A1 PLK4 INHIBITORS Ludwig Institute for Cancer Research Ltd (CH) 2018-02-21 — — EP disclosed
WO-2016166604-A1 PLK4 INHIBITORS LUDWIG INSTITUTE FOR CANCER RESEARCH LTD (CH) 2016-10-20 — — WO disclosed
Send feedback